Gender and Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III

Overview

Journal Drug Alcohol Depend

Publisher Elsevier

Specialty Psychiatry

Date 2015 Sep 17

PMID 26374990

Citations 43

Authors

Bradley T Kerridge

Tulshi D Saha

S Patricia Chou

Haitao Zhang

Jeesun Jung

W June Ruan

Sharon M Smith

Boji Huang

Deborah S Hasin

Affiliations

Soon will be listed here.

Abstract

Background: Little is known about sex-specific risk for nonmedical prescription opioid use (NMPOU) and DSM-5 nonmedical prescription opioid use disorder (NMPOUD). The objective of the present study was to present prevalence, correlates, psychiatric comorbidity, treatment and disability of NMPOU and DSM-5 NMPOUD among men and women.

Methods: Nationally representative sample of the U.S.

Results: Prevalences of 12-month and lifetime NMPOU were greater among men (4.4%, 13.0%) than women (3.9%, 9.8%), while corresponding rates of DSM-5 NMPOUD did not differ between men (0.9%, 2.2%) and women (0.9%, 1.9%). Regardless of time frame and sex, NMPOU and NMPOUD generally decreased with age and were lower among Blacks, Asians/Pacific Islanders and Hispanics, and respondents with lower socioeconomic status. Among men with NMPOU, rates were lower among respondents in the Northeast and South and among those previously married (lifetime). Across time frames and gender, NMPOU and NMPOUD were generally associated with other substance use disorders, posttraumatic stress and borderline, schizotypal and antisocial personality disorders, but associated with major depressive disorder, persistent depression and bipolar I disorder only among men. Disability increased with NMPOU frequency and NMPOUD severity. Only 7.6% and 8.2% of men and women with NMPOU ever received treatment, while 26.8% and 31.1% ever received treatment for NMPOUD.

Conclusions: NMPOU and NMPOUD are highly disabling, associated with a broad array of sex-specific and shared correlates and comorbidities and largely go untreated in the U.S. Valid assessment tools are needed that include gender as a stratification variable to identify NMPOU and NMPOUD.

Citing Articles

Sex and genetic background influence intravenous oxycodone self-administration in the hybrid rat diversity panel.

Duffy E, Ward J, Hale L, Brown K, Kwilasz A, Mehrhoff E Front Psychiatry. 2025; 15:1505898.

PMID: 39758444 PMC: 11695335. DOI: 10.3389/fpsyt.2024.1505898.

Nativity and the risk of opioid use disorder among Hispanic/Latinx women in primary care in Los Angeles, CA.

Takada S, Seamans M, Javanbakht M, Bone C, Ijadi-Maghsoodi R, Shoptaw S J Ethn Subst Abuse. 2024; :1-15.

PMID: 38327151 PMC: 11303597. DOI: 10.1080/15332640.2023.2297392.

Gender differences in the prevalence of stimulant misuse in the United States: 2015-2019.

McHugh R, Korte F, Bichon J, Weiss R Am J Addict. 2023; 33(3):283-289.

PMID: 37924248 PMC: 11032236. DOI: 10.1111/ajad.13501.

Functional genomic mechanisms of opioid action and opioid use disorder: a systematic review of animal models and human studies.

Falconnier C, Caparros-Roissard A, Decraene C, Lutz P Mol Psychiatry. 2023; 28(11):4568-4584.

PMID: 37723284 PMC: 10914629. DOI: 10.1038/s41380-023-02238-1.

Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder.

Paschen-Wolff M, Greenfield S, McHugh R, Burlew K, Pavlicova M, Choo T Am J Addict. 2023; 32(6):584-592.

PMID: 37583120 PMC: 10841329. DOI: 10.1111/ajad.13463.

References

Martins S, Fenton M, Keyes K, Blanco C, Zhu H, Storr C . Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2011; 42(6):1261-72. PMC: 3513363. DOI: 10.1017/S0033291711002145. View

Amari E, Rehm J, Goldner E, Fischer B . Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review. Can J Psychiatry. 2011; 56(8):495-502. DOI: 10.1177/070674371105600808. View

Jamison R, Butler S, Budman S, Edwards R, Wasan A . Gender differences in risk factors for aberrant prescription opioid use. J Pain. 2009; 11(4):312-20. PMC: 2847642. DOI: 10.1016/j.jpain.2009.07.016. View

Sullivan M, Howe C . Opioid therapy for chronic pain in the United States: promises and perils. Pain. 2013; 154 Suppl 1:S94-S100. PMC: 4204477. DOI: 10.1016/j.pain.2013.09.009. View

. The use of abusable prescription drugs: the role of gender. J Womens Health Gend Based Med. 2000; 9(3):289-97. DOI: 10.1089/152460900318470. View

Simoni-Wastila L, Yang H . Psychoactive drug abuse in older adults. Am J Geriatr Pharmacother. 2007; 4(4):380-94. DOI: 10.1016/j.amjopharm.2006.10.002. View

Pollini R, Banta-Green C, Cuevas-Mota J, Metzner M, Teshale E, Garfein R . Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil. 2013; 2(1):173-180. PMC: 3536052. DOI: 10.2147/SAR.S24800. View

Martell B, OConnor P, Kerns R, Becker W, Morales K, Kosten T . Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007; 146(2):116-27. DOI: 10.7326/0003-4819-146-2-200701160-00006. View

McHugh R, DeVito E, Dodd D, Carroll K, Potter J, Greenfield S . Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013; 45(1):38-43. PMC: 3626739. DOI: 10.1016/j.jsat.2012.12.007. View

10.

Miller M, Sturmer T, Azrael D, Levin R, Solomon D . Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc. 2011; 59(3):430-8. PMC: 3371661. DOI: 10.1111/j.1532-5415.2011.03318.x. View

11.

Hasin D, Stinson F, Ogburn E, Grant B . Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007; 64(7):830-42. DOI: 10.1001/archpsyc.64.7.830. View

12.

Kawa I, Carter J, Joyce P, Doughty C, Frampton C, Wells J . Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentation. Bipolar Disord. 2005; 7(2):119-25. DOI: 10.1111/j.1399-5618.2004.00180.x. View

13.

Back S, Payne R, Simpson A, Brady K . Gender and prescription opioids: findings from the National Survey on Drug Use and Health. Addict Behav. 2010; 35(11):1001-7. PMC: 2919630. DOI: 10.1016/j.addbeh.2010.06.018. View

14.

Jamison R, Edwards R . Risk factor assessment for problematic use of opioids for chronic pain. Clin Neuropsychol. 2012; 27(1):60-80. DOI: 10.1080/13854046.2012.715204. View

15.

Tragesser S, Jones R, Robinson R, Stutler A, Stewart A . Borderline personality disorder features and risk for prescription opioid use disorders. J Pers Disord. 2013; 27(4):427-41. DOI: 10.1521/pedi_2013_27_094. View

16.

Bhattacharya A, Khess C, Munda S, Bakhla A, Praharaj S, Kumar M . Sex difference in symptomatology of manic episode. Compr Psychiatry. 2011; 52(3):288-92. DOI: 10.1016/j.comppsych.2010.06.010. View

17.

Novak S, Herman-Stahl M, Flannery B, Zimmerman M . Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States. Drug Alcohol Depend. 2008; 100(1-2):63-70. PMC: 2647685. DOI: 10.1016/j.drugalcdep.2008.09.013. View

18.

Compton W, Thomas Y, Stinson F, Grant B . Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007; 64(5):566-76. DOI: 10.1001/archpsyc.64.5.566. View

19.

Fillingim R, Doleys D, Edwards R, Lowery D . Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine (Phila Pa 1976). 2003; 28(2):143-50. DOI: 10.1097/00007632-200301150-00010. View

20.

Edlund M, Martin B, DeVries A, Fan M, Brennan Braden J, Sullivan M . Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2009; 26(1):1-8. PMC: 2917238. DOI: 10.1097/AJP.0b013e3181b99f35. View